Want to see GB:EDEN full AI Analyst Report?
EDEN Stock Chart & Stats
2.20 p
0.00 p(0.00%)
At close: 4:00 PM EDT
2.20 p
0.00 p(0.00%)
Day’s Range― - ―
52-Week Range1.96 p - 5.00 p
Previous CloseN/A
Volume1.86M
Average Volume (3M)564.08K
Market Cap
£17.67M
Enterprise Value18.76 p
Total Cash (Recent Filing)£1.85M
Total Debt (Recent Filing)£571.86K
Price to Earnings (P/E)―
Beta1.19
Next Earnings
Sep 25, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding803,363,000
10 Day Avg. Volume506,108
30 Day Avg. Volume564,076
Financial Highlights & Ratios
PEG Ratio0.00
Price to Book (P/B)1.23
Price to Sales (P/S)3.92
P/FCF Ratio-6.22
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)>-0.01
Revenue Forecast (FY)£6.10M
Bulls Say, Bears Say
Bulls Say
Conservative Balance SheetVery low leverage and substantial equity provide financial resilience while Eden remains loss-making. This reduces near-term balance-sheet pressure and preserves flexibility to fund product development, registrations and commercial expansion.
Multi-year Revenue GrowthThe multi-year increase indicates that Eden has expanded commercial activity and customer adoption from a small base. Sustained growth in product sales, licensing and partner channels could improve operating leverage as the platform scales.
Positive Gross ProfitPositive gross profit suggests Eden’s products generate value above direct production costs, supporting the potential for a viable commercial model. If scale and partner volumes increase, this gross-profit base could help absorb fixed development and regulatory costs.
Bears Say
Persistent Operating LossesEden has not yet demonstrated recurring operating profitability despite positive gross profit. Continued losses indicate that overhead, research and regulatory spending remain too high relative to revenue, limiting self-funded growth and increasing execution risk.
Recurring Cash BurnNegative operating and free cash flow mean the business is funding operations externally rather than through internally generated cash. Persistent and volatile cash usage can erode its equity cushion and create funding needs before commercial scale is reached.
Uneven Revenue TrajectoryThe recent revenue pullback shows that Eden’s growth is not yet consistent, weakening visibility on commercial scale-up. Uneven sales can delay operating leverage and make the timing of break-even dependent on successful product adoption and partner execution.
Eden Research News
EDEN FAQ
What was Eden Research PLC’s price range in the past 12 months?
Eden Research PLC lowest share price was 1.96 p and its highest was 5.00 p in the past 12 months.
What is Eden Research PLC’s market cap?
Eden Research PLC’s market cap is £17.67M.
When is Eden Research PLC’s upcoming earnings report date?
Eden Research PLC’s upcoming earnings report date is Sep 25, 2026 which is in 26 days.
How were Eden Research PLC’s earnings last quarter?
Currently, no data Available
Is Eden Research PLC overvalued?
According to Wall Street analysts Eden Research PLC’s price is currently Overvalued.
Does Eden Research PLC pay dividends?
Eden Research PLC does not currently pay dividends.
What is Eden Research PLC’s EPS estimate?
Eden Research PLC’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Eden Research PLC have?
Eden Research PLC has 803,363,000 shares outstanding.
What happened to Eden Research PLC’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Eden Research PLC?
Currently, no hedge funds are holding shares in GB:EDEN
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Eden Research PLC
Established in 1995 and headquartered in Abingdon, UK, Eden Research plc specializes in delivering sustainable products for crop protection, animal well-being, and consumer markets throughout the United Kingdom and wider European region. Its agricultural offerings encompass treatments for foliar diseases and insect control, applications for both open fields and greenhouses, soil pest management, methods to extend post-harvest freshness, and seed enhancements. For animal health, the company provides companion animal care items, bio-control agents, parasite remedies, and insect repellent sprays. Additionally, Eden Research produces human health and consumer goods, including head lice treatments, fragrances, deodorants, wound care solutions, food flavorings, odor neutralizers, and supplies of active ingredients.